Individuals with ADHD and comorbid substance use disorder were more likely to discontinue medication and less likely to resume therapy.
Central autism-related features like affect dysregulation and resistance to routine were associated with higher co-occurring symptom severity.
Chronic intranasal oxytocin alters neural connectivity in ASD but fails to significantly improve core behavioral outcomes, according to AAN data.